| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |